Dashboard PDUFA PDUFA History Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...

Free public preview Track ACET with free AI briefings, catalyst countdowns, and dilution alerts.

ACET — Adicet Bio, Inc.

FDA catalysts, PDUFA dates with approval probability, drug pipeline, cash runway and insider activity — updated automatically from SEC, FDA and ClinicalTrials.gov data.

$38.9M Cash on Hand

11.9mo Cash Runway

7.9% Short Interest

🧪 Upcoming Trial Catalysts

2038-08-01 · N/A — Enrolling — Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells

💰 Cash Runway & Dilution Risk

ACET holds $38.9M in cash and burns about $9.8M/quarter from operations, giving an estimated runway of 11.9 months. A recent offering filing was detected — dilution watch.

Source: SEC EDGAR XBRL (operating cash flow). Get dilution alerts for ACET free →

📈 Recent Insider Activity (Form 4)

Date	Insider	Type	Value
2026-01-27	Schor Chen	Sale	$57,561
2026-01-27	Harvey Brian Nicholas	Sale	$43,424
2026-01-27	Healey Don	Sale	$29,135
2026-01-27	Aftab Blake	Sale	$25,160
2025-10-10	ORBIMED ADVISORS LLC	Purchase	$9M

Get the full ACET picture

A free BioRadar account adds AI daily briefings, sentiment tracking, trial enrollment progress, and email alerts for ACET and 2 more tickers of your choice.

Create Free Account →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z